Proton Therapy System Available in Multi-Room Configuration
|
By MedImaging International staff writers Posted on 02 Oct 2019 |

Image: The ProBeam 360° system is now available in multi-room configurations (Photo courtesy of Varian Medical Systems).
The Varian Medical Systems (Varian, Palo Alto, CA, USA) ProBeam 360° system is now available in a multi-room (one to five treatment or research rooms) configuration, which allows cancer centers to tailor the system to meet clinical, research, and capacity needs. Treatment room options include rotating gantries, fixed beam rooms, or eye treatment rooms. Research rooms are available for non-clinical proton beam applications.
The ProBeam 360° system features an extremely powerful cyclotron accelerator, iterative cone-beam computerized tomography (CT) imaging, and high-definition pencil-beam scanning. The 360° rotating gantry enables efficient intensity-modulated proton therapy (IMPT) and faster treatment times by minimizing the need for patient repositioning, thus allowing high-quality cone-beam CT (CBCT) imaging from most angles. RapidScan technology simplifies the process of motion management by delivering each field in a single breath-hold, a capability that increases the number of patients who can comply with breath-hold treatments.
The high-definition pencil-beam scanning technology gives clinicians the ability to deliver dose precisely within the contours of a tumor, minimizing dose to healthy tissue. An iterative CBCT capability enables adaptive precision radiation therapy (RT) during a course of treatment. The system also offers clinicians a viable path to potential next-generation treatments such as Flash therapy. In addition, the ProBeam 360° System offers a 50% smaller volume, a 30% smaller footprint, and 25% lower vault construction cost than Varian’s previous multi-room solution.
“Proton therapy plays an important role in the fight against cancer. The multi-room configuration of ProBeam 360° system provides clinics the flexibility to meet their treatment needs, while also increasing access for patients to proton therapy,” said Kolleen Kennedy, chief growth officer and president of Proton Therapy Solutions at Varian. “Increasing access to advanced treatments like proton therapy is an important step towards achieving our vision of a world without fear of cancer.”
Protons are generated by accelerators in the range of 70 to 250 MeV; by adjusting the energy of the protons during application of treatment, the cell damage due to the proton beam is maximized within the tumor itself. And due to their relatively large mass, protons also have little lateral side scatter in the tissue, staying focused on the tumor. Tissues closer to the surface of the body than the tumor receive reduced radiation, while tissues deeper within the body receive very few protons, so that the dosage becomes immeasurably small.
The ProBeam 360° system features an extremely powerful cyclotron accelerator, iterative cone-beam computerized tomography (CT) imaging, and high-definition pencil-beam scanning. The 360° rotating gantry enables efficient intensity-modulated proton therapy (IMPT) and faster treatment times by minimizing the need for patient repositioning, thus allowing high-quality cone-beam CT (CBCT) imaging from most angles. RapidScan technology simplifies the process of motion management by delivering each field in a single breath-hold, a capability that increases the number of patients who can comply with breath-hold treatments.
The high-definition pencil-beam scanning technology gives clinicians the ability to deliver dose precisely within the contours of a tumor, minimizing dose to healthy tissue. An iterative CBCT capability enables adaptive precision radiation therapy (RT) during a course of treatment. The system also offers clinicians a viable path to potential next-generation treatments such as Flash therapy. In addition, the ProBeam 360° System offers a 50% smaller volume, a 30% smaller footprint, and 25% lower vault construction cost than Varian’s previous multi-room solution.
“Proton therapy plays an important role in the fight against cancer. The multi-room configuration of ProBeam 360° system provides clinics the flexibility to meet their treatment needs, while also increasing access for patients to proton therapy,” said Kolleen Kennedy, chief growth officer and president of Proton Therapy Solutions at Varian. “Increasing access to advanced treatments like proton therapy is an important step towards achieving our vision of a world without fear of cancer.”
Protons are generated by accelerators in the range of 70 to 250 MeV; by adjusting the energy of the protons during application of treatment, the cell damage due to the proton beam is maximized within the tumor itself. And due to their relatively large mass, protons also have little lateral side scatter in the tissue, staying focused on the tumor. Tissues closer to the surface of the body than the tumor receive reduced radiation, while tissues deeper within the body receive very few protons, so that the dosage becomes immeasurably small.
Latest Nuclear Medicine News
- MR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
Channels
Radiography
view channel
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read more
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read moreMRI
view channel
Advanced MRI Visualizes CSF Motion Changes After Mild Traumatic Brain Injury
Mild traumatic brain injury (TBI) can disrupt brain function yet often eludes objective assessment with standard imaging. Clinicians lack tools that capture subtle neurofluid changes that may follow a... Read more
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read moreUltrasound
view channel
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read more
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read moreGeneral/Advanced Imaging
view channel
Routine Cardiac CT Enhanced to Predict Heart Failure Risk
Heart failure, a progressive inability of the heart to pump blood effectively, often develops silently before symptoms appear. Clinicians need reliable ways to detect myocardial injury early and stratify... Read more
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more





 Guided Devices.jpg)

